Navigation Links
Rigel Commences Phase 2 Trial of R788 in Peripheral T-Cell Lymphomas
Date:3/13/2009

llular signaling pathways and related targets that are critical to disease mechanisms. Rigel's productivity has resulted in strategic collaborations with large pharmaceutical partners to develop and market our product candidates. Rigel has product development programs in inflammatory/autoimmune diseases such as rheumatoid arthritis thrombocytopenia and asthma, as well as in cancer.

This press release contains "forward-looking" statements, including statements related to the potential efficacy of R788 for the treatment of refractory or relapsed PTCL, Rigel's plans to pursue further clinical development of R788, enrollment rate in clinical trials of R788 and the timing of results thereof. Any statements contained in this press release that are not statements of historical fact may be deemed to be forward-looking statements. Words such as "believes," "expects" and similar expressions are intended to identify these forward-looking statements. There are a number of important factors that could cause Rigel's results to differ materially from those indicated by these forward-looking statements, including risks associated with the timing and success of clinical trials, potential problems that may arise in the clinical testing and approval process and Rigel's need for additional capital, as well as other risks detailed from time to time in Rigel's reports filed with the Securities and Exchange Commission, including its Form 10-K for the year ended December 31, 2008. Rigel does not undertake any obligation to update forward-looking statements.

    Contact: Raul Rodriguez
    Phone: 650.624.1302
    Email: invrel@rigel.com

    Media Contact: Susan C. Rogers, Alchemy Consulting, Inc.
    Phone: 650.430.3777
    Email: susan@alchemyemail.com


'/>"/>
SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Shareholder Class Action Filed Against Rigel Pharmaceuticals, Inc. by the Law Firm of Barroway Topaz Kessler Meltzer & Check, LLP
2. Rigel Expects R788 Partnership After Phase 2b Clinical Trials Results
3. Rigels R788 Phase 2a Results Published in Arthritis and Rheumatism
4. Rigel to Host Conference Call to Discuss Preliminary Phase 2 Study Results of R788 in Lymphoma
5. Rigels R788 Slows Progression of Murine Lupus in Preclinical Studies
6. Rigels R788 Shows Preclinical Activity in Type 1 Diabetes Model
7. Rigel Announces Initiation of Phase 1 Clinical Trial of R348 for Rheumatoid Arthritis, Psoriasis and Other Immune Disorders
8. Rigels R788 Demonstrates Significant Improvement in Rheumatoid Arthritis in Phase 2 Clinical Study
9. Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer
10. Novexels NXL104/ceftazidime Combination Commences Second Phase II Clinical Trial in Hospital Patients With Complicated Intra-Abdominal Infections (cIAIs)
11. VentiRx Pharmaceuticals Commences Phase I Clinical Trial of VTX-2337, a Novel TLR8 Agonist for the Treatment of Oncology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... YORK , March 6, 2015  Pomerantz LLP ... Pharmaceuticals Inc. ("Conatus" or the "Company") (NASDAQ: ... Robert S. Willoughby at rswilloughby@pomlaw.com or ... Conatus and certain of its officers and/or directors have ... Act of 1934.  On March 5, ...
(Date:3/6/2015)... --  Hospira, Inc. (NYSE: HSP ), applauds ... today,s FDA approval of the first biosimilar in ... for improving patient access to safe, effective and more affordable ... has seen first-hand the positive impact of biosimilars in other ... stages of the development of a pathway for these medicines ...
(Date:3/6/2015)... Fla. , March 6, 2015 ... special validation from Intuitive Surgical, the manufacturer of ... their Triton-36 Instrument Cleaning System. This approval reflects ... standards in cleanliness currently in place for the ... special validation for reprocessing robotic surgical instruments for ...
Breaking Medicine Technology:SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Conatus Pharmaceuticals Inc. - CNAT 2Hospira Statement on FDA Approval of the First Biosimilar in the United States 2Hospira Statement on FDA Approval of the First Biosimilar in the United States 3Ultra Clean Systems Reaches Exclusive Place within Robotic Surgical Instrument Cleaning Industry with Latest Certifications 2
... /PRNewswire-Asia/ -- Mindray Medical International Limited (NYSE: ... medical devices worldwide, announced today an agreement to acquire ... Ltd. ("Greenlander"). The terms of the agreement were not ... statements. Founded in 2003 and based ...
... Better Health ™, a program of Lilly USA, LLC, (NYSE: ... active lives, has launched an expanded Spanish portal on ... Espanol section features a 60-page interactive health album ... and managing health conditions. Additionally, visitors will find more than ...
Cached Medicine Technology:Mindray Medical to Acquire a Controlling Stake in Zhejiang Greenlander Information Technology 2Mindray Medical to Acquire a Controlling Stake in Zhejiang Greenlander Information Technology 3Lilly for Better Health™ Expands Website to Include Spanish Health Information and Interactive Tools 2Lilly for Better Health™ Expands Website to Include Spanish Health Information and Interactive Tools 3
(Date:3/6/2015)... 06, 2015 First Choice Emergency Room ... new facility is located at 13351 W. Bowles Avenue, Littleton, ... team is ready 24-7 to provide the highest quality emergency ... Medical Director of First Choice Emergency Room Littleton. ... the South Metro Denver Chamber of Commerce and a medical ...
(Date:3/6/2015)... Magellan Rx Management’s 2014 Medical Pharmacy ... key trends and statistics on one of the nation’s ... Magellan Rx Management will discuss key findings from the ... Specialty Drug Spend,” a complimentary March 19 webinar, managed ... drug spend makes up more than a quarter of ...
(Date:3/6/2015)... In a new study conducted at a Warsaw hospital, ... pain was their first mesothelioma symptom. Surviving Mesothelioma has just ... to read it now. , Doctors at the Central ... mesothelioma patients between 2006 and 2012 and found ... that first prompted them to see a doctor. For some, ...
(Date:3/6/2015)... You Wealth Revolution ( http://www.youwealthrevolution.com/info ... ‘energy’ experiment to determine if quick remote meditations ... quick ‘5 -7 minute’ remote energy and consciousness ... their life improving - often times very quickly. ... According to research, respondents saw the following common ...
(Date:3/6/2015)... March 06, 2015 The producers of ... air dates for Spokane, Washington and vicinity. This is a ... shop and dine, and many outdoor activities. It is also ... local economy. Six major hospitals call the city home and ... border. The medically-focused cable TV program will be broadcast on ...
Breaking Medicine News(10 mins):Health News:First Choice Emergency Room Opens New Facility in Littleton, Colorado 2Health News:Atlantic Information Services, Magellan Rx Management Partner on Complimentary Webinar Outlining Key Findings of New Medical Pharmacy Trend Report 2Health News:New Report Reveals Shoulder Pain Could Signal Early Mesothelioma, According to Surviving Mesothelioma 2Health News:250,000+ Person ‘Remote Energy’ Event has 94.2% of Respondents saying “Life Got Better” 2Health News:The Health Briefs TV Show to Air in Spokane, Washington 2
... ... Public Relations ( http://www.5wpr.com ) , one of the 25 largest PR firms ... Stein ( http://www.philipstein.com/ ) watches to its versatile roster of fashion and ... be a leader in watches and other lifestyle products using proprietary natural frequency ...
... Researchers from the Boston University School of Medicine ... which is over activated in late-stage cancers, is ... patterns of regulatory DNA hypermethylation causing silencing of ... findings, which appear online in Cancer Research ...
... infections, genetics and the environment are complex and mysterious. ... to autoimmune diseases like rheumatoid arthritis and lupus? How ... disease? Our immediate environment interacts with our genetic ... an autoimmune disease, says rheumatologist Prof. Michael Ehrenfeld of ...
... ... with its parent company Logan Consulting, a Chicago IL based consulting and technology firm, effective ... ... Certified partner, today announced it will merge with its parent company Logan Consulting, a Chicago ...
... calories per meal for their children, study found ... information is available on fast-food restaurant menus, parents are ... new research finds. , Often spurred on by legislation, ... about their menu items. But whether this information would ...
... A new, in-home ... disease was presented by lead researcher Dr. Alberto Espay at the American Acadamy of Neurology ... (PRWEB) January ... of gait in people with Parkinson,s disease (PD). , , , , ,It is well ...
Cached Medicine News:Health News:5W Public Relations Adds Philip Stein Watches to Its Fashion & Lifestyle Client Roster 2Health News:5W Public Relations Adds Philip Stein Watches to Its Fashion & Lifestyle Client Roster 3Health News:Discovery of epigenetic memory during breast cancer 2Health News:How arthritis thrives 2Health News:Cornerstone Solutions Merges with Logan Consulting 2Health News:Cornerstone Solutions Merges with Logan Consulting 3Health News:Listing Calories on Fast-Food Menus Cuts Kids' Intake 2Health News:Listing Calories on Fast-Food Menus Cuts Kids' Intake 3Health News:New Treatment for Parkinson's Disease Gait Presented at the American Acadamy of Neurology Annual Meeting 2Health News:New Treatment for Parkinson's Disease Gait Presented at the American Acadamy of Neurology Annual Meeting 3
... The CA-1000 counts a Petri dish in ... the optical characteristics of the colonies as ... CA-1000 is equipped with three types of ... lighter or darker than the agar and ...
Basic critical care testing. Measures pH, pCO2, and pO2 from 85 L whole-blood sample....
... sophisticated whole blood analysis system that is ... satisfying the stringent requirements of the central ... all of the components of a traditional ... sampling unit, all of the sensors and ...
The AVL Omni modular system is a complete blood gas solution designed for high-volume critical care use, with customized test combinations, minimum intervention and flexibility....
Medicine Products: